Medical Properties Trust MPT Income Statement (2009-2026)

NYSE MPT
$3.90 -0.09 (-2.13%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Medical Properties Trust Quarterly Income Statement

Periods 66 quarters
Latest Mar 2026

Medical Properties Trust reported revenue of $252.06M and net income of $33.11M for the quarter ended Mar 2026, up 12.6% year over year. This income statement covers 66 quarters of results from Dec 2009 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue
381.79M390.78M409.33M409.80M400.23M352.34M380.49M350.21M337.39M306.58M11.00M271.32M266.56M225.83M231.84M223.80M240.36M237.52M270.34M252.06M
Operating items
Selling, General & AdministrativeSG&A
34.55M36.69M38.33M41.42M38.86M37.32M42.89M41.72M35.60M38.11M30.15M33.35M35.33M36.62M28.49M41.91M26.20M37.73M24.59M32.20M
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
187.36M186.30M186.02M185.10M193.20M178.21M181.20M188.62M493.55M190.99M182.93M189.09M211.33M316.11M176.20M187.41M207.29M208.38M209.10M212.99M
Operating ExpensesOpex
221.90M222.99M224.34M226.52M232.06M215.53M224.09M230.35M529.15M229.10M213.08M222.44M246.66M352.74M204.69M229.32M233.49M246.12M233.69M245.19M
Operating IncomeOp. Inc
EBIT
257.31M276.13M305.63M734.51M288.45M328.68M-32.88M134.23M-86.22M233.66M-557.26M-755.74M-203.67M-685.65M-301.29M7.22M41.44M65.82M158.56M133.62M
Non-operating items
Non Operating Interest Expenses
92.31M94.13M93.98M91.18M87.73M88.08M92.05M97.65M104.47M106.71M102.34M108.69M101.43M106.24M101.47M115.80M129.71M132.40M132.46M133.33M
Non Operating Investment IncomeNon-Op. Investment Inc.
-1.39M9.29M43.58M451.64M16.36M68.80M-0.03M0.06M0.17M-0.02M-2.02M-1.42M384.82M91.80M4.00M8.06M5.21M-9.12M1.39M-0.79M
Interest & Investment IncomeInt & Inv Inc
59.12M33.26M32.66M33.58M48.63M42.36M41.68M32.17M60.77M29.69M0.04M10.89M16.77M9.71M11.37M8.58M12.91M10.17M11.92M10.29M
Other Non Operating IncomeOther Non Op Inc.
-0.77M-2.28M40.95M14.76M2.03M4.08M-5.53M-5.17M-3.23M41.12M-17.86M-229.34M-167.69M-169.79M-48.74M-45.21M-124.43M-1.50M-1.41M-2.50M
Non Operating IncomeNon Op. Inc.
5.11M14.21M26.66M460.05M32.55M103.79M-281.32M-83.29M1.06M49.48M-324.14M-913.31M-325.00M-664.99M-429.91M-103.06M-95.14M-57.98M-10.55M-6.59M
Net income details
EBT
165.00M182.00M211.65M643.33M200.72M240.60M-124.93M36.57M-190.69M126.95M-659.60M-864.43M-305.10M-791.90M-402.76M-108.58M-88.27M-66.58M26.10M0.28M
Tax ProvisionsTaxes
50.18M10.60M84.34M11.38M10.66M5.00M160.93M3.54M-148.26M10.06M-9.56M10.95M14.56M9.03M-531.02M9.44M9.80M10.87M-79.95M-32.82M
Profit After TaxPAT
114.82M171.40M206.84M631.95M190.06M222.02M-140.21M33.03M-42.43M116.89M-663.97M-875.38M-319.66M-801.16M-412.85M-118.28M-98.07M-77.73M17.31M33.11M
Equity Income
7.34M7.19M6.86M7.34M14.79M11.48M7.19M11.35M12.22M11.26M0.03M10.55M-401.76M21.64M2.92M13.99M25.32M34.40M24.14M15.74M
Income from Non-Controlling InterestsInc. Minority
0.26M0.26M0.31M0.27M0.47M0.23M5.08M0.24M-0.40M0.18M7.01M0.25M0.98M0.23M12.50M0.26M0.29M0.28M0.28M0.28M
Income from Continuing OperationsIncome (Continuing)
114.82M171.40M127.31M631.95M190.06M235.60M-285.85M33.03M-42.43M116.89M-650.04M-875.38M-319.66M-800.93M128.26M-118.02M-98.07M-77.45M106.05M33.11M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
114.82M171.40M127.31M631.95M190.06M235.60M-285.85M33.03M-42.43M116.89M-650.04M-875.38M-319.66M-800.93M128.26M-118.02M-98.07M-77.45M106.05M33.11M
Income towards Parent CompanyParent Net Inc
114.82M171.40M127.31M631.95M190.06M235.60M-285.85M33.03M-42.43M116.89M-650.04M7.00M2.00M50.00M20.00M28.00M36.00M46.50M10.70M
Net Income towards Common StockholdersNet Income
114.82M171.40M127.31M631.95M190.06M235.60M-285.85M33.03M-42.43M116.89M-650.04M7.00M2.00M50.00M20.00M28.00M36.00M46.50M10.70M
Additional items
EPS (Basic)
0.200.290.221.060.320.39-0.480.06-0.070.20-1.090.010.000.080.030.050.060.080.02
EPS (Diluted)
0.190.290.221.060.320.39-0.480.06-0.070.20-1.090.010.000.080.030.050.060.080.02
Shares Outstanding
587.51M595.12M588.82M598.68M598.83M598.98M598.63M598.30M598.34M598.44M598.52M600.30M600.06M600.23M600.25M600.59M600.81M601.14M600.89M597.72M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
589.05M597.32M590.14M598.93M599.03M599.34M598.84M598.31M598.34M598.55M598.52M600.30M600.06M600.23M600.25M600.59M600.81M601.14M600.89M597.72M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
588.96M596.14M596.75M598.68M598.84M598.98M597.48M598.30M598.34M598.44M598.99M600.30M600.06M600.23M600.40M600.60M600.81M601.14M597.01M597.72M
EBITDA
257.31M276.13M305.63M734.51M288.45M328.68M-32.88M134.23M-86.22M233.66M-557.26M-755.74M-203.67M-685.65M-301.29M7.22M41.44M65.82M158.56M133.62M
Interest ExpensesInt Expense
92.31M94.13M93.98M91.18M87.73M88.08M92.05M97.65M104.47M106.71M102.34M108.69M101.43M106.24M101.47M115.80M129.71M132.40M132.46M133.33M
Tax Rate
30.41%5.83%39.85%1.77%5.31%2.08%-128.82%9.69%77.75%7.92%1.45%-1.27%-4.77%-1.14%131.84%-8.69%-11.11%-16.33%-306.28%-11,516.49%